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Background: Non-melanoma skin cancers (NMSCs) are the most frequently seen cancers worldwide.
Methods: The medical records of patients diagnosed with basal cell carcinoma (BCC) and squamous cell carcinoma
(SCC) in Hatay Antakya pathology laboratory between January 2010 and September 2012 were retrospectively included
in the study. Tumors were categorized according to age, gender, anatomical localization, type, solitary-multiplicity,
tumor diameter (0 to 2 mm, 2.1 to 6 mm and >6.1 mm), and presence of ulceration (BCCs), and morphological
subtype, histopatological features and grades (SCCs).
Results: A total of 136 tumors in 127 NMSC cases were examined. Solitary tumors were seen in 118 (92.9%),
and multiple tumors in 9 (7.1%) patients. Mean age of the patients was 68.5 ± 13 years. BCC was observed in 96 (75.6%)
and SCC in 31 (24.4%) patients. Mean diameter of all types of solitary and multiple tumors was 7.42 ± 3.49 mm. Nodular
subtype focal cystic changes were observed in 49 (47.6%) patients. All tumors (solitary and multiple) were seen on the
face (67.6%), scalp (11.8%), and ear (11%). Well differentiated SCCs were detected in 20 cases (64.5%); ulceration was
observed in 58.1% of all tumors.
Conclusions: Epidemiologic and histopathological investigations, routine skin scanning performed on the elderly
population and dermatological examination will help to improve efficient health applications.
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Non-melanoma skin cancers (NMSCs) are frequent in the
United States with an estimated incidence of approxi-
mately two million cases per year [1]. NMSC caused
75,000 deaths between 1976 and 2000 [2]. NMSCs are
mostly seen on the head or neck, and ≥90% of all skin
cancers consist of basal cell carcinoma (BCC) or squamous
cell carcinoma (SCC) [3]. Genetic factors, ultraviolet
radiation (UVR), especially ultraviolet B (UVB) which
contributes to the formation of SCCs and BCCs, are
also implicated in the development of NMSCs [4]. In
Hatay, Turkey, with a population of 1,474,000 people,
where 32% of the city population live in the center of
the city and the others in rural areas (latitude: 36 25′
49″ N, longitude: 36 10′ 27″ E), most of the people
work in agriculture, animal husbandry and commerce.
In summer the climate is hot and arid, and in winters it
is mild and rainy (characteristic Mediterranean climate).Correspondence: alikoyuncuer@hotmail.com
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The aim of the present study was to clarify the clini-
copathologic features and morphological characteristics
of NMSCs diagnosed in skin biopsies in Hatay, where
ultraviolet exposure might be higher than in other regions
of Turkey.Methods
Study design
This study was approved by the local Institutional
Review Board (Antakya State Hospital). In the study, we
re-examined 4 μm sections of formalin-fixed and paraffin-
embedded basal cell and squamous cell skin cancer
specimens, and stained them with hematoxylin and
eosin, except for malignant melanoma, precancerous
malignancies, non-invasive lesions and other malig-
nancies in Hatay Antakya State Hospital’s pathology
laboratory between January 2010 and September 2012.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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anatomical localization, type, solitary/multiplicity, tumor
diameter (0 to 2 mm, 2.1 to 6 mm and >6.1 mm), presence
of ulceration (BCCs), and morphological subtype, histopa-
tological features, and grades (SCCs). BCCs were catego-
rized as nodular (solid), micronodular, cystic, superficial
(superficial multifocal), pigmented, adenoid, infiltrating,
sclerosing/morpheoform, keratocystic, basosquamous and
adnexal differentiation, and mixed patterns. Other rarely
seen types mentioned in the literature were not observed
[3,4]. SCCs were categorized as grade 1 (well differentiated
tumors), 2 (moderately differentiated tumors), 3 (poorly
differentiated tumors), and 4 (anaplastic or undifferenti-
ated tumors), based on the classification of the College of
American Pathologists (CAP) and the TNM Classification
of Malignant Tumours (International Union Against
Cancer 2009) [5]. Patient age was categorized as 20 to
40 years, 41 to 50 years, 51 to 60 years, 61 to 70 years,
71 to 80 years, and >81 years. NMSCs were seen on the
face (frontal, temporal, orbital, zygomatic, nasal, infra-
orbital, parotid, oral, buccal, mental regions), scalp, ear,
neck, trunk, and extremities [6].
Statistical analyses
Data were analyzed using the Statistical Package for Social
Sciences (SPSS) software (version 15.0 for Windows; SPSS
Inc., Chicago, IL, USA). The t-test was used for comparing
averages, the chi-test was used for comparing dispersion
of two groups, and the Kruskal-Wallis-H test was used for
comparing dispersion of multi-groups. All differences
associated with a chance probability of 0.05 or less were
considered statistically significant. Continuous variables
are presented as mean ± SD.
Results
A total of 127 NMSC cases examined between January
2010 and September 2012 were reported.
Solitary/multiple
Solitary tumors were seen in 118 (92.9%), and multiple
tumors in 9 (7.1%) patients.
Age
Mean age of the patients was 68.5 ± 13.6 (range 27 to
94) years. Mean ages of the cases diagnosed as BCC and
SCC were 67.2 ± 13.9 and 72.4 ± 11.8 years, respectively.
No statistically significant difference was found between
groups (P = 0.062). The median age detected in men for
BCC was 67.3 years, and in women was 67 years; for
SCC, median ages were 69.8 years for men, and 76.7
years for women. Distribution of cases among age groups
were as follows: 20 to 40 years, 2.4%; 41 to 50 years,
11.8%; 51 to 60 years, 11.8%; 61 to 70 years, 18.1%; 71 to
80 years, 37.8%; and >81 years, 18.1%. Median age of thecases with multiple tumors was 71.1 years. No statistically
significant difference was found between age groups and
cancer types (P = 0.410).
Gender
Among 72 men (56.7% of the total) and 55 women
(43.3% of the total), BCC was observed in 53 men
(41.7%) and 43 women (33.8%). SCCs were detected in
19 men (15.06%) and 12 women (9.44%). Male or female
dominancy was not observed among cases with multiple
tumors. No statistically significant difference was found
between genders and cancer types (P = 0.556).
Cancer type
BCC was observed in 96 (75.6%) and SCC in 31 (24.4%)
patients. Most (77.8%) of the multiple tumors were
determined as BCC. Patient demographic features such
as cancer type, gender and age are summarized in Table 1.
Greatest diameter of the tumors
Mean diameter of all types of solitary and multiple tumors
was 7.42 ± 3.49 mm. Mean tumor diameters for BCC and
SCC were 7.08 ± 2.940 (range 2 to 15) mm and 8.48 ± 3.93
(range 3 to 22) mm, respectively. Mean diameters of all
solitary and multiple tumors were 7.6 ± 3.311 mm and
7 ± 2.5 mm, respectively. A correlation was detected be-
tween cancer types and tumor dimensions (P = 0.030).
Tumors were categorized according to their greatest
diameters as: 0 to 2 mm (1.5%), 2.1 to 6 mm (45.6%),
and ≥6.1 mm (52.9%).
Basal cell carcinoma morphological subtype
Solitary and multiple tumors (total n = 103) in 96 BCC
patients were evaluated. Nodular (solid) subtype focal
cystic changes were observed in 49 (47.6%), mixed pat-
terns in 29 (28.2%), infiltrating type in 13 (12.6%), adenoid
in 7 (6.8%), micronodular in 3 (2.9%), superficial cancer in
1 and basosquamous in 1, respectively. Distribution of
morphological subtypes of basal cell carcinoma is shown
in Table 2.
Predominantly nodular subtype was detected among
mixed types. Nodular (solid) types (pure or mixed) were
the most frequently seen types of tumors (67%). Focal
pigmentations were detected in 12.5% of all 12 BCC
patients. No statistically significant difference was found
between pigmentations and BCC subtypes (P = 0.927).
Squamous cell carcinoma differentiation
Well-differentiated (grade 1) SCCs were detected in 20
cases (64.5%), and moderately differentiated (grade 2)
SCCs were found in 35.5% of the cases. All multiple
SCCs were moderately differentiated. In our study, grade
3 (poorly differentiated) and 4 (anaplastic or undifferen-
tiated) tumors were not detected.
Table 1 Relation between cancer type, gender, age and rates in patients
Cancer
type
Male Female Total number
Mean age (years) n Mean age (years) n n (%)
BCC 67.3 53 67 43 96 (75.6)
SCC 69.8 19 76.7 12 31 (24.4)
Total 72* 55* 127 (100)
*Number (n). BCC, basal cell carcinoma; SCC, squamous cell carcinoma.
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All tumors (solitary and multiple) were seen on the face
(67.6%), scalp (11.8%), and ear (11%). Significant differ-
ences were detected between cancer type and anatomic
localization (P = 0.008), and 74.8% of BCCs were localized
on the face. In our study, 92.7% of all BCCs (89 patients)
were solitary, while 7 patients had BCCs on more than
one anatomic location. BCCs were detected on the nose
(n = 30; 29.1%), ear (10.7%), scalp (6.8%), and frontal
region (5.8%). SCCs were seen on the face (n = 15; 8%)
and scalp (n = 8). All multiple tumors were seen on the
face, except for one patient (nose,4; zygomatic/buccal
region, 4; mental region, 2; orbital region, 1; lip, 1; scalp, 1;
ear, 1). SCCs were multiple in two patients (face, 1; ear, 1;
scalp, 1; extremity, 1). When relations between BCC
subtypes and anatomic localizations were investigated,
nodular subtypes were seen on the face (76.9%; n = 39),
nose (34.7%), frontal (10.2%) and orbital regions (10.2%).
Figure 1 shows morphological subtypes of BCCs and their
anatomic locations.
Nodular (solid) types, consisting of a nodular nest of
basal cell types which have peripheral palisading of
lesional cell nuclei, a specialized stroma, tumor necrosis
and focal cystic changes, were seen. In certain cases,
particular nodular subtypes with one or more than one
cystic space of different size and shape or cystic degenera-
tions were observed. Nodular (solid) types, with cystic
changes in the central part of the tumor nest, are shown
in Figure 2. Mixed subtypes were seen on the face (58.6%),
nose (64.7%), and ear (17%). Adenoid subtypes were
seen on the face except in one patient. Adenoid typeTable 2 Basal cell carcinoma morphological subtypes
distribution
BCC morphological subtypes n (%)
Nodular (solid) 49 (47.6%)




Superficial (multifocal) 1 (1.0%)
Basosquamous 1 (1.0%)
Total 103 (100.0%)
BCC, basal cell carcinoma.was characterized as nodular (solid) type, with mucoid
appearance in tubular stroma, and gland-like structures
(pseudoglandular appearance). Infiltrative subtypes were
seen on the face (84.6%), and nose (45.5%). Histological
features consisted of cord-like, elongated strands of
basaloid cells infiltrating between collagen bundles,
and palisading of the peripheral cells. Some cases,
especially with nodular subtypes, had melanophages in
the stroma and melanocytes within tumor islands which
had melanin granules in dark-staining cytoplasm showed
pigmentations. Along with mixed types in six patients
and in patients with pure superficial multifocal types,
on epidermal surface, ulcerations, and from epidermis
to dermis buds and irregular proliferations, tumors
which generate clefting between dermal layers, superficial
type that had pigmentation on its center and melanin
pigments on solid tumor nests were observed. Nodular
subtypes was observed in all multiple BCCs (nodular;
pure type, 6; mixed type, 1; adenoid,1; mixed, 1; micro-
nodular, 1). SCCs were detected on the face (48.4%),
scalp (26%), nose and extremities with decreasing order
of frequencies. Well differentiated SCCs were detected
on the face (40%), scalp (30%), and extremities (15%). Well
differentiated SCC (grade 1) is a tumor which consists of
irregular masses of epidermal cells which show decreased
dermal proliferation. Abundant keratinization/keratocysts,Figure 1 Morphological subtypes of basal cell carcinomas (BCCs)
and their anatomic locations.
Figure 2 Basal cell carcinoma of the nodular (solid) type, with
cystic change present. (Hematoxylin and eosin, x200).
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vesicles, minimal pleomorphism, and minimal mitosis in
the center of the tumor were seen (Figure 3). Moderately
differentiated SCCs were seen on the face (63.6%). Moder-
ately differentiated (grade 2) squamous cell carcinoma,
nuclear and cytoplasmic pleomorphisms, keratin forma-
tion, horn cyst, and individually scattered keratinized cells
were seen predominantly.Ulceration
Ulceration was observed in 58.1% of all tumors. Ulceration
was detected in 55.3% of BCCs and 66.7% of SCCs. No
statistically significant difference was found between
ulceration and cancer types (P = 0.247). In cases with and
without ulcerations, greatest diameters of the tumors
were found to be 6.30 ± 3.438 mm and 8.23 ± 2.864 mm,
respectively. A statistically significant inverse correlationFigure 3 Squamous cell carcinoma, well differentiated, shows
keratocysts. (Hematoxylin and eosin, x200).was found between ulceration and the greatest diameter
(P = 0.001).
Discussion
NMSCs are malignant neoplasms that displays basal cell
and squamuos cell differentiation [7]. Defined by Unna
in 1896, solar radiation is the main etiologic factor for
human NMSCs [8]. In 1934, Roffo demonstrated the
effect of solar light on skin malignancies [9]. Exposure
to sunlight is the most frequent principal factor in the
etiology of squamous cells cancers. Along with ionized
radiation, other risk factors for SCCs are chemical carcin-
ogens, arsenic, immunosuppression, ulcers, and precursor
lesions [10]. BCCs are the most frequently seen skin
cancers and malignant neoplasia is mostly observed on
the skins of Caucasians [11,12]. In our study, BCC was
the most frequently seen NMSC.
BCC usually develops from solar radiation to the skin.
Having fair skin, being employed outside, x-ray exposure,
chickenpox scars, tattoos, and hair transplantation scars
are other etiological factors [11]. The earth’s surface is
exposed to 95% ultraviolet A (UVA, 320–400 mm), and
1 to 5% UVB (290–320 mm). UVB radiation may be
more of a risk for BCC, and UVB causes BCC more
commonly than UVA [8]. They include prolonged expos-
ure to solar radiation is on the basis of risk for SCC. High
ultraviolet exposure causes SCC more commonly than it
causes BCC [7]. Smokers were asked about the type of
tobacco product they used (cigarettes, cigars, pipe or a
combination of these products). Smoking-related cancers
are usually of the lung, lip, pharynx, larynx, salivary glands
and leukemia, but Sitas and colleagues found a weak
correlation between smoking and BCC [13]. McBride and
colleagues [14] found that smoking did not increase the
risk of SCC. De Hertog and colleagues [15] detected that
smoking is an unrelated cause for skin SCC, reporting that
there was no correlation between smoking and BCC and
melanoma. Karagas and colleagues emphasized that the
higher risk of SCC related with smoking value anymore
training [16].
NMSCs have been shown to be BCCs in 80% of
instances, and 20% are SCCs [17]. Our BCC and SCC
rates were observed to be close to these percentages. A
study in Australia showed that NMSCs were seen at an
incidence of 884/100,000 population for BCC, and 387/
100,000 for SCC [18]. Somewhat less than 5% of
NMSCs are diagnosed before the age of 40 [19]. In our
study their incidence was 97.6% which is in accordance
with the literature. BCC is seen more frequently in
older age groups. SCC occurs most frequently in elderly
people. Incidence of SCCs increases from the age of 75
years [4,10].
In our study, BCC was observed more often in men.
In the literature, age, gender and localization studies
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seen approximately at the age of 65 years [20], while
another study demonstrated that BCCs were seen in
women at a rate of 53.8% at a median age of 70.3 years
[21]. The authors also recorded that SCCs were seen in
men with an incidence of 50.8%, and at a mean age of
74.4 (±12.4) years [21]. In our study, SCCs were seen in
men more than women and mean age of their onset
was closer to those mentioned in the literature. Most
(82.8%) of BCCs involved head and neck regions, and
17.2% of them were found on the trunk, and limb
region. Andrade and colleagues [21] and Yap [22]
showed that most BCCs were identified on the face
(62.9%) (nose, 29.4%; zygomatic prominence, 21.4%,
and forehead, 14.7%).
SCCs are frequently reported to be located on the
head and neck area, with 51.9% on the face (zygomatic
prominence, 31%; lower lip, 17.8%; ear, 11.7%; forehead,
11.5%, and nose, 10.1%), while the other most common
site was the trunk [10,21,23]. In our study, BCC and
SCC were seen most frequently on the face and neck
area. In addition, SCC was more frequently seen on
the face, and then on the scalp. A study showed that
ulceration was not observed in 18% of cases with BCC
[22]. In our study, ulceration was seen in more than
half of the cases, and thus our rates were different from
the literature findings. According to CAP, ulceration was
not one of the high risk histologic features for SCC [5].
Cherpelis and colleagues noted that ulceration was not
associated with the spread of the tumor [24]. BCC
tumors of the neck and head had high relapse rates.
While recurrences were not observed for lesions which
were smaller than 2 mm, recurrence rates observed for
6 to 10 mm lesions and those greater than 30 mm in
diameter were 8.8% and 23.1%, respectively [25]. Brantsch
and colleagues [26] reported that tumors ≤2 mm did
not show recurrence, those greater than 2.0 mm in
thickness carried a risk of metastasis, and tumors big-
ger than 6 mm had higher risks of metastasis and local
recurrence. Greatest diameter of the tumors was found
to be ≥6.1 mm in 52.9% of the patients included in the
study (72 cases), but any evidence of metastasis and
death was not found in hospital and pathology records.
Various opinions have been suggested for the morpho-
logical subtypes of BCC. Weedon [3] and Haws and
colleagues [27] opined that the mixed type is most fre-
quently seen, but a study showed that the solid variant
is most frequently seen [28], and superficial multicentric
and solid-adenoid variants were observed. Puizina-Ivić
and colleagues observed pure and mixed variants at a
rate of 83.1% and 16.9%, respectively [28]. Nakjang and
Kullavanijaya [29] opined that pigmentation was most
frequently seen in solid, superficial and adenoid sub-
types. Yap [22] suggested that the most frequently seenwas the nodular type (95.3%) followed by superficial
BCC; however, Scrivener and colleagues [20] reported
that nodular, superficial, and morphoeiform types were
seen at rates of 78.7%, 15.1% and 6.2%, respectively. In
our study, the nodular subtype was seen at a rate in
accordance with the literature, but mixed subtypes were
ranked second. Corrêa and colleagues recorded that
well differentiated types were the most frequently seen
type of SCC, followed by the moderately differentiated
type [30]. In our study, most of the SCCs were of the
well differentiated type, and poorly differentiated (grade
3) and anaplastic or undifferentiated (grade 4) types were
not observed. This was attributed to the development of
lesions on visible areas of the body and early diagnosis.
Conclusions
At the end of our study period in which age of onset,
gender of the patients, histological type, subtype and
anatomic locations of the NMSCs were examined, it is
possible to say that exposure to ultraviolet radiation is
the major potential etiologic factor for cancer considering
the geographic and climatic factors of the Hatay region
and that people are outdoor workers employed in agricul-
ture and animal husbandry. Epidemiologic and histopath-
ologic investigations, routine skin screening performed on
the elderly population, and dermatological examination
will help to improve efficient health applications. NMSCs
were found in the those older than 60 years and most
frequently on the face and, most often, the nodular
subtype of BCC was detected.
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